Lovly et al. later confirmed that IMT is a largely oncogene-driven neoplasia [43], and that tumorigenesis is associated with the translocation of receptor tyrosine kinase genes, such as ALK and ROS-1 [22]. This evidence concerns the gene ALK and inflammatory myofibroblastic tumor.